SGS principals have been actively involved with AlphaBio CEO Dr. Ophir Fromovich for over a year. Dr. Fromovich is the innovator of the predecessor to the NobelActive implant which will be launched in the second quarter of this year. With this move, Nobel Biocare will reinforce its leading position in the industry and gain access to Alpha Bio’s cutting edge product line and market share.

Congratulations Dr. Fromovich and others at Alpha Bio from your friends at SGS.

Official Media Release